Purpose To analyze the visual acuity (VA) of patients with and without vitreous loss, while concurrently analyzing the effects of the pre-existing pathologies of glaucoma and diabetes on VA. Methods A ...

Please provide your email address to receive an email when new articles are posted on . GLP-1RA use was associated with a 19% reduction in risk for glaucoma in patients with type 2 diabetes. Long-term ...

Diabetes and hyperglycemia are associated with thicker central corneal thickness (CCT), which could lead to overestimation of intraocular pressure when assessing patients for glaucoma, new research ...

GLP-1 receptor agonists may reduce glaucoma risk in T2D patients, though the reduction was nonsignificant. The review included five high-quality observational studies with over 2.5 million ...

A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the ...

The earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness ...

Blurry vision can be an early warning sign of diabetes. It's also a sign of advanced diabetic eye disease. If blood sugar goes uncontrolled, diabetes causes progressive damage to structures in the ...

Glaucoma causes irreversible vision loss affecting 80 million people; World Glaucoma Week 2026 urges early eye exams, awareness, and treatment to prevent blindness.

Add Yahoo as a preferred source to see more of our stories on Google. It’s one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually that ...

Experts explain whether Lasik or lens implants affect your risk, and how a hair strand-like microshunt could reduce reliance on lifelong eye drops for patients.